Mito Target

  • Choose your Language:

    • Français
    • , 
    • Deutsch
    • , 
    • Español
    • , 
    • Nederlands
  • Home
    • Public & Patients
    • Scientists & Physicians
    • Institutions & Investors

You are here / Home » Public & Patients

Mito Target News RSS

The information provided in this web site is intended to educate the reader about certain medical conditions and certain possible treatments. It is not a substitute for examination, diagnosis, and medical care provided by a licensed and qualified health professional. If you believe you, suffer from the conditions described herein, please see your health care provider. Do not attempt to treat yourself or anyone else without proper medical supervision.
Read the Full Disclaimer

Yes, I have read the Full Disclaimer

Public & Patients

What is ALS?

What is ALS? What are clinical trials? FAQs & Support

Discover more

What are Clinical Trials?

A clinical trial is one of the final stages of a long and careful pharmaceutical research process.

Get Support

Find out more on the disease and get support

Latest News

Actelion joins forces with Trophos to further advance olesoxime to the market once results of the MitoTarget clinical study are known.

20 July 2010

Actelion obtains option to acquire privately-held Trophos Late-stage Phase III compound in Amyotrophic Lateral Sclerosis to report data in late 2011 – Novel therapeutic approach to be furth

Trophos completes patients enrolment in ALS trial

17 March 2010

Trophos completes patient enrolment in pivotal phase 3 efficacy study of olesoxime in Amyotrophic Lateral Sclerosis (Lou Gehrig's disease) Topline results of the study are expected 4th quarter 20

MitoTarget Launches New Online Resource for Physicians and Sufferers from Rare Illness ALS (also known as Lou Gehrig’s disease)

8 March 2010

Marseille, France, March 8, 2010 - Trophos, the pharmaceutical company specialising in therapies for orphan diseases including ALS, announces today, on behalf of the MitoTarget consortium, the lau

See all News Items

  • Public & Patients
    • What is ALS?
    • What are Clinical Trials?
    • Get Support
    • MitoTarget Trial
    • Ask the Specialists
  • Scientists & Physicians
  • Institutions & Investors
  • News
  • Contact Us
  • Choose your Language:

    • Français
    • , 
    • Deutsch
    • , 
    • Español
    • , 
    • Nederlands
  • © Copyright 2010
  • Home
    • Public & Patients
    • Scientists & Physicians
    • Institutions & Investors

The MitoTarget project is supported by the European Union under the 7th Framework Programme for RTD - Project MitoTarget - Grant Agreement HEALTH-F2-2008-223388

Seventh Framework Programme European Union